KRISTI SHOOK HUNTER M.D. NPI 1356411474

NPI Details

Kristi Shook Hunter, M.D. is an emergency medicine in Sylvania, GA with 32 years of experience. The provider is an emergency physician focuses on the immediate decision making and action necessary to prevent death or any further disability both in the pre-hospital setting by directing emergency medical technicians and in the emergency department. The emergency physician provides immediate recognition, evaluation, care, stabilization and disposition of a generally diversified population of adult and pediatric patients in response to acute illness and injury. Kristi Shook Hunter, M.D. NPI is 1356411474. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Graduation Year:1994

The provider's business location address is:

215 MIMS RD
SYLVANIA, GA
ZIP 30467-994
Phone: (912) 564-7426

The NPI 1356411474 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, vedolizumab, 1 mg (HCPCS:J3380)
• Injection, ocrelizumab, 1 mg (HCPCS:J2350)
• Injection, omalizumab, 5 mg (HCPCS:J2357)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, mepolizumab, 1 mg (HCPCS:J2182)
• Injection, inclisiran, 1 mg (HCPCS:J1306)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, tezepelumab-ekko, 1 mg (HCPCS:J2356)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, tildrakizumab, 1 mg (HCPCS:J3245)
• Injection, benralizumab, 1 mg (HCPCS:J0517)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)

The enumeration date for this NPI number is 11/8/2006 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.